Quarterly report [Sections 13 or 15(d)]

Balance Sheets (Unaudited)

v3.25.3
Balance Sheets (Unaudited) - USD ($)
Sep. 30, 2025
Dec. 31, 2024
Current assets    
Cash $ 3,806,978 $ 4,091,990
Acquired patents, net 1,779
Total assets 3,806,978 4,093,769
Current liabilities    
Accounts payable & accrued interest 1,108,886 1,177,536
Deferred compensation – related party 306,281 306,281
Unreimbursed expenses – related party 206,834 75,916
Total current liabilities 1,622,001 1,559,733
Total liabilities 1,622,001 1,559,733
Stockholders’ equity    
Common stock, $0.001 par value; 100,000,000 shares authorized; 13,794,577 and 13,152,729 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively 13,795 13,153
Additional paid-in capital 79,760,045 68,674,261
Accumulated deficit (77,588,863) (66,153,378)
Total stockholders’ equity 2,184,977 2,534,036
Total liabilities and stockholders’ equity $ 3,806,978 $ 4,093,769